Braskem (BAK) Expected to Announce Earnings on Thursday

Braskem (NYSE:BAKGet Free Report) is anticipated to release its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect Braskem to post earnings of ($0.16) per share for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Tuesday, November 11, 2025 at 7:00 AM ET.

Braskem (NYSE:BAKGet Free Report) last posted its earnings results on Thursday, August 7th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.70) by $0.56. The company had revenue of $3.38 billion for the quarter, compared to analysts’ expectations of $18.76 billion. On average, analysts expect Braskem to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Braskem Stock Performance

BAK opened at $2.42 on Wednesday. The stock has a market capitalization of $962.63 million, a price-to-earnings ratio of -0.95 and a beta of 1.76. The company has a fifty day moving average of $2.88 and a 200 day moving average of $3.26. Braskem has a fifty-two week low of $2.32 and a fifty-two week high of $6.34.

Institutional Investors Weigh In On Braskem

An institutional investor recently raised its position in Braskem stock. Jump Financial LLC grew its stake in shares of Braskem S.A. (NYSE:BAKFree Report) by 607.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 263,771 shares of the company’s stock after acquiring an additional 226,467 shares during the period. Jump Financial LLC owned about 0.07% of Braskem worth $865,000 at the end of the most recent quarter.

Analyst Ratings Changes

Several research firms recently weighed in on BAK. Santander cut shares of Braskem from a “neutral” rating to an “underperform” rating in a research note on Thursday, October 16th. UBS Group cut shares of Braskem from a “buy” rating to a “neutral” rating and cut their target price for the company from $5.10 to $3.80 in a research note on Friday, September 26th. JPMorgan Chase & Co. cut their target price on shares of Braskem from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday, August 27th. Weiss Ratings reissued a “sell (e+)” rating on shares of Braskem in a research note on Wednesday, October 8th. Finally, Citigroup cut shares of Braskem from a “buy” rating to a “hold” rating in a research note on Friday, October 10th. Five analysts have rated the stock with a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Braskem presently has an average rating of “Reduce” and a consensus price target of $4.40.

Check Out Our Latest Report on BAK

Braskem Company Profile

(Get Free Report)

Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.

Read More

Earnings History for Braskem (NYSE:BAK)

Receive News & Ratings for Braskem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braskem and related companies with MarketBeat.com's FREE daily email newsletter.